{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:16:45Z","timestamp":1782371805652,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT24MS018"],"award-info":[{"award-number":["DUT24MS018"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Liaoning Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["Grants2023-MSBA-018and2025-MS-023"],"award-info":[{"award-number":["Grants2023-MSBA-018and2025-MS-023"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Liaoning Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023-MSBA-018 and2025-MS-023"],"award-info":[{"award-number":["2023-MSBA-018 and2025-MS-023"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.dmd.2026.100244","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:16:12Z","timestamp":1769213772000},"page":"100244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unveiling polymerization-dependent pharmacokinetics and dual oxidative metabolism of polyethylene glycol 600 oligomers in rats via ultra-high-performance liquid chromatography coupled to tandem mass spectrometry"],"prefix":"10.1016","volume":"54","author":[{"given":"Jiye","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunpeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dmd.2026.100244_bib1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.4103\/1673-5374.208597","article-title":"Polyethylene glycol as a promising synthetic material for repair of spinal cord injury","volume":"12","author":"Kong","year":"2017","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.dmd.2026.100244_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125758","article-title":"Unraveling the pharmaceutical excipient-drug interactions: the effects of polyethylene glycol copolymers on drug metabolism and transport systems","volume":"680","author":"Shang","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.dmd.2026.100244_bib3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jconrel.2021.07.041","article-title":"Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates","volume":"337","author":"Tedeschini","year":"2021","journal-title":"J Control Release"},{"issue":"9","key":"10.1016\/j.dmd.2026.100244_bib4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/17425247.2016.1182485","article-title":"Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications","volume":"13","author":"D'Souza","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"issue":"36","key":"10.1016\/j.dmd.2026.100244_bib5","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew Chem Int Ed Engl"},{"issue":"21","key":"10.1016\/j.dmd.2026.100244_bib6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.dmd.2026.100244_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J Control Release"},{"issue":"Pt A","key":"10.1016\/j.dmd.2026.100244_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"10.1016\/j.dmd.2026.100244_bib9","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.jaip.2021.03.002","article-title":"Hidden dangers: recognizing excipients as potential causes of drug and vaccine hypersensitivity reactions","volume":"9","author":"Caballero","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.dmd.2026.100244_bib10","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/jps.24424","article-title":"The \u201cNew Polyethylene Glycol Dilemma\u201d: polyethylene glycol impurities and their paradox role in mAb crystallization","volume":"104","author":"Hildebrandt","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.dmd.2026.100244_bib11","article-title":"Advances in aptamer-based drug delivery vehicles for cancer therapy","volume":"140","author":"Ghasemii","year":"2022","journal-title":"Biomater Adv"},{"key":"10.1016\/j.dmd.2026.100244_bib12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.dmd.2026.100244_bib13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/14686996.2019.1627174","article-title":"PEGylated liposomes: immunological responses","volume":"20","author":"Mohamed","year":"2019","journal-title":"Sci Technol Adv Mater"},{"issue":"11","key":"10.1016\/j.dmd.2026.100244_bib14","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.1021\/acs.biomac.4c01169","article-title":"Ultrasensitive in vitro and ex vivo tracking of (13)C-labeled PEG-PLA degradation products by MALDI-TOF mass spectrometry","volume":"25","author":"Khong","year":"2024","journal-title":"Biomacromolecules"},{"issue":"6","key":"10.1016\/j.dmd.2026.100244_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/dmd.121.000568","article-title":"The in vivo pharmacokinetics of block copolymers containing polyethylene glycol used in nanocarrier drug delivery systems","volume":"50","author":"Yin","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.dmd.2026.100244_bib16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4155\/bio.10.204","article-title":"In vitro and in vivo characterizations of PEGylated liposomal doxorubicin","volume":"3","author":"Jiang","year":"2011","journal-title":"Bioanalysis"},{"issue":"6","key":"10.1016\/j.dmd.2026.100244_bib17","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.3390\/molecules17066348","article-title":"Zinc phthalocyanine labelled polyethylene glycol: preparation, characterization, interaction with bovine serum albumin and near infrared fluorescence imaging in vivo","volume":"17","author":"Lv","year":"2012","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.dmd.2026.100244_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00518484","article-title":"Appearance of 14C-polyethylene glycol 4000 in intestinal venous blood: influence of osmolarity and laxatives, effect on net water flux determination","volume":"321","author":"Winne","year":"1982","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.dmd.2026.100244_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.117083","article-title":"Unraveling the plasma dynamics, oxidative metabolism and excretion behavior of M-PEG6-OH by UPLC-MS\/MS","volume":"266","author":"Guo","year":"2025","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"10.1016\/j.dmd.2026.100244_bib20","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.apsb.2021.11.016","article-title":"The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers","volume":"12","author":"Fan","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.dmd.2026.100244_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0168-8278(05)80520-3","article-title":"Hepatic excretion and metabolism of polyethylene glycols and mannitol in the cat","volume":"17","author":"Friman","year":"1993","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100244_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/dmd.106.012419","article-title":"PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies","volume":"35","author":"Webster","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2026.100244_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpba.2018.12.030","article-title":"Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?","volume":"165","author":"Kaza","year":"2019","journal-title":"J Pharm Biomed Anal"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:34:52Z","timestamp":1776180892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626000139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0090955626000139"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100244","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling polymerization-dependent pharmacokinetics and dual oxidative metabolism of polyethylene glycol 600 oligomers in rats via ultra-high-performance liquid chromatography coupled to tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100244"}}